{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:51:52Z","timestamp":1791348712514,"version":"4.3.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intracranial hemorrhage (ICH) is the leading cause of early death in acute promyelocytic leukemia (APL). Current risk assessment relies on static coagulation parameters at admission, but APL-associated coagulopathy evolves rapidly. Whether dynamic changes in coagulation markers predict hematoma expansion remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether the fibrinogen decline rate and D-dimer increase rate predict hematoma expansion in APL-related ICH, and to compare their predictive performance with static admission values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective cohort study included 68 APL patients with spontaneous ICH. Hematoma expansion was defined as absolute growth &amp;gt;12.5\u2005mL or relative growth &amp;gt;33% on follow-up CT. To ensure temporal precedence of the predictors relative to the outcome, the fibrinogen decline rate and D-dimer increase rate were calculated over a fixed 24-hour landmark window from the first CT-confirmed ICH (T0) to 24\u2005h (T1). Multivariable models were adjusted for baseline fibrinogen and D-dimer levels. Logistic regression and receiver operating characteristic analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hematoma expansion occurred in 22 patients (32.4%). The fibrinogen decline rate independently predicted expansion in multivariate analysis after adjustment for the baseline fibrinogen level (OR 1.92 per 0.1\u2005g\/L\/day, 95% CI 1.35\u20132.74,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), while the D-dimer increase rate did not (OR 1.07, 95% CI 0.95\u20131.21,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.28). The AUC for the fibrinogen decline rate was 0.85, outperforming the static admission fibrinogen level (AUC 0.68) and the absolute fibrinogen nadir (AUC 0.70). The combined model achieved an AUC of 0.94 (bootstrap 95% CI 0.87\u20130.99). The optimal cut-off for the fibrinogen decline rate was 0.35\u2005g\/L\/day (sensitivity 77.3%, specificity 80.4%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The dynamic fibrinogen decline rate independently predicts hematoma expansion in APL-related ICH and outperforms static admission values. Serial coagulation monitoring in the first 24\u2005h may enable earlier identification of high-risk patients. The proposed cut-off of 0.35\u2005g\/L\/day warrants prospective validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1956224","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:45:38Z","timestamp":1791348338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic fibrinogen decline rate outperforms static admission values in predicting hematoma expansion in APL-related intracranial hemorrhage: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Wentao","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Neurosurgery, Ganzhou People's Hospital","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Hematology, Ganzhou People's Hospital","place":["Ganzhou, China"]},{"name":"Jiangxi Health Commission Key Laboratory of Leukemia, the Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"722614","DOI":"10.3389\/fmed.2021.722614","article-title":"Coagulopathy in acute promyelocytic leukemia: can we go beyond supportive care","volume":"8","author":"Hambley","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.3390\/cancers15133477","article-title":"The coagulopathy of acute promyelocytic leukemia: an updated review of pathophysiology, risk stratification, and clinical management","volume":"15","author":"Hermsen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12185-022-03515-5","article-title":"The characteristics and long-term outcomes of acute promyelocytic leukemia patients with early intracranial hemorrhage","volume":"117","author":"Li","year":"2023","journal-title":"Int J Hematol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/blood.2024026186","article-title":"Acute promyelocytic leukemia: long-term outcomes from the HARMONY project","volume":"145","author":"Voso","year":"2025","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1597070","DOI":"10.3389\/fmed.2025.1597070","article-title":"Exploration of neuroprotective strategies in patients with acute promyelocytic leukemia complicated by cerebral hemorrhage","volume":"12","author":"Hu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2017.09.011","article-title":"ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia","volume":"62","author":"Sahai","year":"2017","journal-title":"Leuk Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e808","DOI":"10.1016\/S2352-3026(25)00236-4","article-title":"Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study","volume":"12","author":"Yin","year":"2025","journal-title":"Lancet Haematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e26026","DOI":"10.7759\/cureus.26026","article-title":"Coagulation abnormalities and risk assessment in acute promyelocytic leukemia: an experience from a resource-constraint country","volume":"14","author":"Thakur","year":"2022","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","first-page":"102499","DOI":"10.1016\/j.rpth.2024.102499","article-title":"Hemorrhage in acute promyelocytic leukemia-fibrinolysis in focus","volume":"8","author":"Sabljic","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"B10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12185-024-03708-0","article-title":"Dysregulated hemostasis in acute promyelocytic leukemia","volume":"119","author":"Hisada","year":"2024","journal-title":"Int J Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1634441","DOI":"10.3389\/fneur.2025.1634441","article-title":"Predicting hemorrhage expansion in patients with hypertensive intracerebral hemorrhage: the HE-VSD-A2TP score","volume":"16","author":"Zhu","year":"2025","journal-title":"Front Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1182\/bloodadvances.2022006980","article-title":"CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition","volume":"6","author":"Wang","year":"2022","journal-title":"Blood Adv"},{"key":"B13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.thromres.2021.12.020","article-title":"Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia","volume":"210","author":"Xiao","year":"2022","journal-title":"Thromb Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1182\/bloodadvances.2023010466","article-title":"Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia","volume":"7","author":"Hisada","year":"2023","journal-title":"Blood Adv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"106174","DOI":"10.1016\/j.leukres.2019.106174","article-title":"Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction","volume":"83","author":"Hambley","year":"2019","journal-title":"Leuk Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/09537104.2020.1799969","article-title":"Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia","volume":"32","author":"Chu","year":"2021","journal-title":"Platelets"},{"key":"B17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.leukres.2010.05.022","article-title":"Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia","volume":"35","author":"Kim","year":"2011","journal-title":"Leuk Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.62347\/AUHX4651","article-title":"Establishment and validation of a 28-day clinical outcome prediction model for acute promyelocytic leukemia based on an early platelet-coagulation factor combined transfusion strategy","volume":"16","author":"Zheng","year":"2026","journal-title":"Am J Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1089\/neu.2018.6234","article-title":"Fibrinolytic activation in patients with progressive intracranial hemorrhage after traumatic brain injury","volume":"38","author":"Fair","year":"2021","journal-title":"J Neurotrauma"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.3390\/cancers15143637","article-title":"Management of acute promyelocytic leukemia at extremes of age","volume":"15","author":"Kayser","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13054-021-03541-5","article-title":"Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies","volume":"25","author":"Kudo","year":"2021","journal-title":"Crit Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1055\/a-1393-8302","article-title":"Management of disseminated intravascular coagulation in acute leukemias","volume":"41","author":"Ten Cate","year":"2021","journal-title":"H\u00e4mostaseologie"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/ajh.27264","article-title":"Changing hemostatic management in post-partum hemorrhage","volume":"1","author":"Rigouzzo","year":"2024","journal-title":"Am J Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.leukres.2016.09.006","article-title":"Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia","volume":"50","author":"Lou","year":"2016","journal-title":"Leuk Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1956224\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:45:56Z","timestamp":1791348356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1956224\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":24,"alternative-id":["10.3389\/fmed.2026.1956224"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1956224","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1956224"}}